Dr. Alfred Rémillard
B.Sc., B.Sc.(Pharm.) (Man.), Pharm.D.(Philadelphia), B.C.P.P.
Professor of Pharmacy and Associate Dean Research and Graduate AffairsThorvaldson 220
Phone: 306-966-6345
Fax: 306-966-6377
aj.remillard@usask.ca
Dr. Rémillard has been a member of faculty since 1983. He is also an Associate Member of the Department of Psychiatry, College of Medicine.
Teaching Responsibilities:
Undergraduate courses in Therapeutics and Pharmacy Practice.
Clinical Practice:
Clinical Psychopharmacology Consultant, Saskatoon City Hospital.
Chief Areas of Pharmaceutical Interest:
Pharmacotherapy in psychiatric and neurologic disorders; pharmacy practice issues; drug use in the elderly; and pharmacoeconomics.
Recent research involves all areas of clinical psychopharmacology research including clinical trials; pharmacokinetics; pharmacoepidemiology; pharmacoeconomics; pharmacy practice; and pharmaceutical care projects .
Published Works:
Z. Austin, D. Collins, A. Rémillard, S. Kelcher and S. Chui, 2006. Influence of Attitudes Toward Curriculum on Dishonest Academic Behavior, American Journal of Pharmaceutical Education, 70, 1-9.
A.J. Rémillard, 2004. “Canadian Drug Information” Appendix G. In: Pharmacology For Nursing Care, 5th Edition by R.A. Lehne, L.A. Moore, L.J. Crosby and D.B. Hamilton, W.B. Saunders Co., Philadelphia.
J. Fang, G. McKay, J.X. Song, A.J. Rémillard, X.M. Li and K.K. Midha, 2001. In Vitro Characterization of the Metabolism of Haloperidol using Recombinant Cytochrome P450 Enzymes and Human Liver Microsomes, Drug Metab. Dispos., 12, 1-6.
P.S. Melnyk, Y.M. Shevchuk and A.J. Rémillard, 2000. Impact of the Dial Access Drug Information Service on Patient Outcome, The Annals of Pharmacotherapy, 34, 585-592.
A.J. Rémillard, 1998. “Canadian Drug Information” (Appendix G). In: Pharmacology for Nursing Care, 3rd Edition by R.A. Lehne, L.A. Moore, L.J. Crosby and D.B. Hamilton, W.B. Saunders Co., Philadelphia.
A.J. Rémillard, 1998. “Legal Implications Related to the Pharmacologic Aspects of Nursing Practice” (Chapter 2). In: Pharmacology in Nursing Practice, 4th Edition by G.E. Johnson, M. Osis and K.J. Hannah, W.B. Saunders Co., Toronto.
A.J. Rémillard, 1996. A Pharmacoepidemiological Evaluation of Anticholinergic Prescribing Patterns in the Elderly, Pharmacoepidemiology and Drug Safety, 5, 155-164.
Y.M. Shevchuk and A.J. Rémillard, 1996. Pain and Fever. In: Nonprescription Drugs, A Reference for Health Professionals, 5th Edition, Canadian Pharmaceutical Association, Ottawa.
A.J. Rémillard, 1995. A Review of Moclobemide and the Monoamine Oxidase Inhibitors, Communication, 20, 7-15.
A.J. Rémillard, 1994. A Review of the Selective Serotonin Reuptake Inhibitors, Communication, 19, 9-16.
A.J. Rémillard, 1994. A Pilot Project to Assess the Association of Anticholinergic Symptoms with Anticholinergic Serum Levels in the Elderly, Pharmacotherapy, 14, 482-487.
A.J. Rémillard, S.L. Blackshaw and A. Dangor, 1994. Differential Response to a Single Antidepressant in Recurrent Episodes of Major Depression, Hospital and Community Psychiatry, 45, 359-361.
S. Livingstone, R. Bowen, A. Rémillard and S. Wallace, 1994. Drug and Health Utilization by Patients with Anxiety Neurosis in Saskatchewan, Canada, Pharmacoepidemiology, 3, S52.
A.J. Rémillard, R. O'Reilly, D.K. Gorecki, S.L. Blackshaw, D. Quinn and D.L. Keegan, 1993. The Noncompliance Factor in the Dexamethasone Suppresion Test, Biological Psychiatry, 33, 755-756.
Research Category Key Words:
Clinical Research, Psychopharmacology, Psychiatry.
